CDC Discovers More Blood Clotting Issues With COVID Vaccine


by Joseph Mercola, Mercola:

As reported by Reuters and Medscape, the CDC has documented more cases of potentially life-threatening blood clotting — called thrombosis with thrombocytopenia syndrome or TTS — among people who received the Johnson & Johnson COVID-19 vaccine.

The agency has now identified 28 cases of TTS among the more than 8.7 million people who received the J&J vaccine. So far, three of the 28 have died. The update supersedes the agency’s April 25 report of 17 cases of clotting issues among nearly 8 million vaccinated people.


The blood-clotting issues are similar to what happened following administration of the AstraZeneca COVID-19 vaccine in Europe, and the TTS syndrome does not appear to be occurring with the Pfizer or Moderna COVID-19 vaccines, the CDC said.

Most of the blood-clotting complications occurred in women aged 18 to 49, with rates among women aged 30-39 at 12.4 cases per million and those aged 40-49 at 9.4 cases per million, according to the report. Data show only six cases among men.

Read More @